Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Genzada Pharmaceuticals USA, Inc.
University of Zurich
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University Health Network, Toronto